439P Testing HR+ / HER2- patients with advanced or metastatic breast cancer for identification of tissue mutations in the PIK3CA gene: Results of a national program by the Hellenic Society of Medical Oncology (HeSMO)
Boutis, A., Nikolaou, M., Ardavanis, A., Tolis, C., Loga, K., Korantzis, I., Koumarianou, A., Christopoulou, A.N., Papatsimpas, G., Bokas, A., Pliarchopoulou, K., Kampletsas, E., Kesisis, G., Biziota, E., Psianou, K., Karageorgopoulou, S., Sogka, E.A., Tsoukalas, N.G., Chatzifoti, N., Saridaki-Zoras, Z.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article